logo

Altamira Therapeutics Ltd Inc. (CYTO) Price Performance: The Role of Supply and Demand

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -57.76% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -55.99%. Over the past 30 days, the price of CYTO has leaped by -37.45%. And in the last five days, it has fallen by -0.68%.

Altamira Therapeutics Ltd experienced a rather shaky stock market performance. The highest value in the past year was recorded at $28.40 on 05/04/23 and the lowest value was $1.38 on 04/23/24.

52-week price history of CYTO Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Altamira Therapeutics Ltd’s current trading price is -94.82% away from its 52-week high, while its distance from the 52-week low is 6.51%. The stock’s price range during this period has varied between$1.38 and $28.40. The Altamira Therapeutics Ltd’s shares, which operate in the Healthcare, saw a trading volume of around 2.8 million for the day, a figure considerably higher than their average daily volume of 1.18 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Altamira Therapeutics Ltd (CYTO) has experienced a quarterly decline of -35.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.32M and boasts a workforce of 12 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.6731, with a change in price of -11.4205. Similarly, Altamira Therapeutics Ltd recorded 984,629 in trading volume during the last 100 days, posting a change of -88.60%.

CYTO Stock Stochastic Average

As of today, Altamira Therapeutics Ltd’s raw stochastic average for the last 50 days stands at 4.24%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 8.06%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 9.01% and 5.74%, respectively.